Page last updated: 2024-09-03

reboxetine and Menopause

reboxetine has been researched along with Menopause in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Gougoulaki, M; Lewis, G; Nutt, DJ; Peters, TJ; Wiles, NJ	1

Trials

1 trial(s) available for reboxetine and Menopause

Article	Year
Sex differences in depressive symptoms and tolerability after treatment with selective serotonin reuptake inhibitor antidepressants: Secondary analyses of the GENPOD trial. Journal of psychopharmacology (Oxford, England), 2021, Volume: 35, Issue:8 Topics: Adrenergic Uptake Inhibitors; Adult; Citalopram; Depression; Female; Humans; Male; Menopause; Middle Aged; Reboxetine; Selective Serotonin Reuptake Inhibitors; Sex Factors; Treatment Outcome	2021

Article

Year

Sex differences in depressive symptoms and tolerability after treatment with selective serotonin reuptake inhibitor antidepressants: Secondary analyses of the GENPOD trial.

Journal of psychopharmacology (Oxford, England), 2021, Volume: 35, Issue:8

Topics: Adrenergic Uptake Inhibitors; Adult; Citalopram; Depression; Female; Humans; Male; Menopause; Middle Aged; Reboxetine; Selective Serotonin Reuptake Inhibitors; Sex Factors; Treatment Outcome

2021